Secreted forms of DELTA and SERRATE define antagonists of Notch signaling in Drosophila
- PMID: 9310338
- DOI: 10.1242/dev.124.17.3439
Secreted forms of DELTA and SERRATE define antagonists of Notch signaling in Drosophila
Abstract
We examined the function of secreted forms of the two known Drosophila Notch ligands, DELTA and SERRATE, by expressing them under various promoters in the Drosophila developing eye and wing. The phenotypes associated with the expression of secreted Delta (DlS) or secreted Serrate (SerS) forms mimic loss-of-function mutations in the Notch pathway. Both genetic interactions between DlS or SerS transgenics and duplications or loss-of-function mutations of Delta or Serrate indicate that DlS and SerS behave as dominant negative mutations. These observations were extended to the molecular level by demonstrating that the expression of Enhancer of split mdelta, a target of Notch signaling, is down-regulated by SERS. The antagonistic nature of the two mutant secreted ligand forms in the eye is consistent with their behavior in the wing, where they are capable of down-regulating wing margin specific genes opposite to the effects of the endogenous ligands. This analysis uncovers secreted molecular antagonists of Notch signaling and provides evidence of qualitative differences in the actions of the two ligands DLS and SERS.
Similar articles
-
The intracellular deletions of Delta and Serrate define dominant negative forms of the Drosophila Notch ligands.Development. 1996 Aug;122(8):2465-74. doi: 10.1242/dev.122.8.2465. Development. 1996. PMID: 8756291
-
Feed-back mechanisms affecting Notch activation at the dorsoventral boundary in the Drosophila wing.Development. 1997 Sep;124(17):3241-51. doi: 10.1242/dev.124.17.3241. Development. 1997. PMID: 9310319
-
Delta is a ventral to dorsal signal complementary to Serrate, another Notch ligand, in Drosophila wing formation.Genes Dev. 1996 Feb 15;10(4):421-34. doi: 10.1101/gad.10.4.421. Genes Dev. 1996. PMID: 8600026
-
A dominant-negative form of Serrate acts as a general antagonist of Notch activation.Development. 1997 Sep;124(17):3427-37. doi: 10.1242/dev.124.17.3427. Development. 1997. PMID: 9310337
-
Structural conservation of Notch receptors and ligands.Semin Cell Dev Biol. 1998 Dec;9(6):599-607. doi: 10.1006/scdb.1998.0260. Semin Cell Dev Biol. 1998. PMID: 9918871 Review.
Cited by
-
Origin and evolution of the Notch signalling pathway: an overview from eukaryotic genomes.BMC Evol Biol. 2009 Oct 13;9:249. doi: 10.1186/1471-2148-9-249. BMC Evol Biol. 2009. PMID: 19825158 Free PMC article.
-
The cell giveth and the cell taketh away: an overview of Notch pathway activation by endocytic trafficking of ligands and receptors.Acta Histochem. 2011 May;113(3):248-55. doi: 10.1016/j.acthis.2010.01.006. Epub 2010 Feb 1. Acta Histochem. 2011. PMID: 20122714 Free PMC article. Review.
-
Mutational analysis of the Notch2 negative regulatory region identifies key structural elements for mechanical stability.FEBS Open Bio. 2015 Jul 30;5:625-33. doi: 10.1016/j.fob.2015.07.006. eCollection 2015. FEBS Open Bio. 2015. PMID: 26288744 Free PMC article.
-
Phenotype-based clustering of glycosylation-related genes by RNAi-mediated gene silencing.Genes Cells. 2015 Jun;20(6):521-42. doi: 10.1111/gtc.12246. Epub 2015 May 4. Genes Cells. 2015. PMID: 25940448 Free PMC article.
-
E-cadherin-defective gastric cancer cells depend on Laminin to survive and invade.Hum Mol Genet. 2015 Oct 15;24(20):5891-900. doi: 10.1093/hmg/ddv312. Epub 2015 Aug 5. Hum Mol Genet. 2015. PMID: 26246502 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous